Pulse Biosciences (NASDAQ:PLSE) Stock Rating Upgraded by StockNews.com

Pulse Biosciences (NASDAQ:PLSE) was upgraded by analysts at StockNews.com to a “sell” rating in a research note issued to investors on Monday.

Pulse Biosciences Price Performance

NASDAQ:PLSE opened at $15.94 on Monday. Pulse Biosciences has a 1 year low of $6.60 and a 1 year high of $25.00. The business has a fifty day moving average of $18.71 and a 200-day moving average of $18.14.

Institutional Trading of Pulse Biosciences

A number of hedge funds and other institutional investors have recently made changes to their positions in PLSE. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of Pulse Biosciences during the third quarter valued at approximately $588,000. Charles Schwab Investment Management Inc. increased its position in shares of Pulse Biosciences by 193.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 148,114 shares of the company’s stock valued at $2,598,000 after purchasing an additional 97,565 shares during the period. State Street Corp raised its stake in shares of Pulse Biosciences by 17.8% in the 3rd quarter. State Street Corp now owns 461,333 shares of the company’s stock worth $8,092,000 after buying an additional 69,696 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Pulse Biosciences by 7.8% in the third quarter. Geode Capital Management LLC now owns 457,165 shares of the company’s stock valued at $8,020,000 after buying an additional 33,200 shares during the period. Finally, Franklin Resources Inc. bought a new position in Pulse Biosciences during the third quarter valued at about $378,000. 76.95% of the stock is currently owned by institutional investors.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.